0001824293-24-000116.txt : 20240823 0001824293-24-000116.hdr.sgml : 20240823 20240823160511 ACCESSION NUMBER: 0001824293-24-000116 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240823 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240823 DATE AS OF CHANGE: 20240823 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GRI BIO, Inc. CENTRAL INDEX KEY: 0001824293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 824369909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40034 FILM NUMBER: 241236274 BUSINESS ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 208 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (619) 400-1171 MAIL ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 208 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Vallon Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20200910 8-K 1 val-20240823.htm 8-K val-20240823
FALSE000182429300018242932024-08-232024-08-23

Image_0.jpg

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 23, 2024
Image_8.jpg
GRI BIO, INC.
(Exact name of registrant as specified in its charter)
Delaware001-4003482-4369909
(State or other jurisdiction(Commission File Number)(IRS Employer Identification No.)
of incorporation)
2223 Avenida de la Playa, Suite 208
La Jolla, CA 92037
(Address of principal executive offices and zip code)
(619) 400-1170
(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)
Image_8.jpg
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
GRI
The Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Image_0.jpg

Image_8.jpg




Item 5.07 Submission of Matters to a Vote of Security Holders
On August 23, 2024, GRI Bio, Inc. (the “Company”) convened and then adjourned its 2024 Annual Meeting of Stockholders (the “Annual Meeting”). The Company previously filed a Definitive Proxy Statement, dated August 2, 2024, as amended and supplemented to date (as amended and supplemented, the “Proxy Statement”). A total of 741,914 shares of the Company’s common stock were entitled to vote on June 27, 2024, the record date for the Annual Meeting, and 256,566 shares of common stock, or approximately 34.58% of the shares entitled to vote, were present or represented by proxy at the Annual Meeting. Per the Company’s amended and restated bylaws, a quorum requires the presence, in person or by proxy, of the holders of one-third of the voting power of the stock outstanding and entitled to vote at the Annual Meeting. As a result, there was a quorum present for the Annual Meeting. The only matter submitted to a vote of stockholders at the Annual Meeting was the proposal regarding adjournment of the Annual Meeting as further described in Proxy Statement, and the voting results for this proposal are set forth below.
After the vote on this adjournment proposal, the Company adjourned the Annual Meeting to Friday, September 6, 2024 at 11:00 a.m., Eastern Time, virtually at www.virtualshareholdermeeting.com/GRI2024 to allow for the solicitation of additional proxies to adopt the remaining proposals set forth in the Proxy Statement for the Annual Meeting.
Adjournment Proposal
The proposal to approve any postponement or adjournment of the Annual Meeting, from time to time, if necessary, to solicit additional proxies if there were not sufficient votes at the time of the Annual Meeting to adopt the proposals set forth in the proxy statement or to establish a quorum was approved as follows:
Votes ForVotes AgainstVotes AbstainedBroker Non-Votes
157,45599,09516



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 23, 2024GRI Bio, Inc.
By: /s/ Leanne Kelly
Leanne Kelly
Chief Financial Officer



EX-101.SCH 2 val-20240823.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 val-20240823_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Ex Transition Period Entity Ex Transition Period Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cover [Abstract] Written Communications Written Communications Entity Address, Address Line Two Entity Address, Address Line Two Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security City Area Code City Area Code Document Period End Date Document Period End Date Amendment Flag Amendment Flag Entity Tax Identification Number Entity Tax Identification Number Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Pre-commencement Tender Offer Pre-commencement Tender Offer Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 val-20240823_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 5 val-20240823_g1.jpg GRAPHIC begin 644 val-20240823_g1.jpg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val-20240823_g2.jpg GRAPHIC begin 644 val-20240823_g2.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Cover
Aug. 23, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Aug. 23, 2024
Entity Registrant Name GRI BIO, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-40034
Entity Tax Identification Number 82-4369909
Entity Address, Address Line One 2223 Avenida de la Playa
Entity Address, Address Line Two Suite 208
Entity Address, City or Town La Jolla
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92037
City Area Code 619
Local Phone Number 400-1170
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol GRI
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001824293
Amendment Flag false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2.u1 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://wwwvallon-pharma.com/role/Cover Cover Cover 1 false false All Reports Book All Reports val-20240823.htm val-20240823.xsd val-20240823_lab.xml val-20240823_pre.xml val-20240823_g1.jpg val-20240823_g2.jpg http://xbrl.sec.gov/dei/2024 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "val-20240823.htm": { "nsprefix": "val", "nsuri": "http://wwwvallon-pharma.com/20240823", "dts": { "inline": { "local": [ "val-20240823.htm" ] }, "schema": { "local": [ "val-20240823.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd" ] }, "labelLink": { "local": [ "val-20240823_lab.xml" ] }, "presentationLink": { "local": [ "val-20240823_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 23 }, "report": { "R1": { "role": "http://wwwvallon-pharma.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "val-20240823.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "val-20240823.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r6" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://wwwvallon-pharma.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r5" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001824293-24-000116-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001824293-24-000116-xbrl.zip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end XML 17 val-20240823_htm.xml IDEA: XBRL DOCUMENT 0001824293 2024-08-23 2024-08-23 false 0001824293 8-K 2024-08-23 GRI BIO, INC. DE 001-40034 82-4369909 2223 Avenida de la Playa Suite 208 La Jolla CA 92037 619 400-1170 false false false false Common Stock, par value $0.0001 per share GRI true false